Cut-off: 20 October 2026.
Scope and entity attribution
Citibank, N.A. is a principal wholly owned indirect subsidiary of Citigroup Inc.; it is legally distinct from other Citigroup subsidiaries such as Citigroup Global Markets Inc.1 Bank of Israel currently lists Citibank n.a as a supervised foreign bank in Israel, reporting symbol 22001.2 [pre-2020] Bank of Israel research says the Citibank N.A. branch began operating in Israel in 2000 and initially focused on large-company banking services.3 [pre-2020] A 2015 SEC subcustodian filing separately identifies Citibank, N.A., Israel Branch in Tel Aviv.4
Citi-branded technology and venture activity is not automatically attributable to Citibank, N.A. Israel Branch. The retrieved sources variously name Citi, Citi Ventures, Citibank, N.A., Citigroup Global Markets Inc.; this audit attributes each act to the entity actually named by the source.1, 5, 6
Enterprise Technology Stack & Vendor Relationships
Israeli-origin software and services. No public evidence identified in the bounded searches of a direct Citibank, N.A. licensing/subscription contract with Check Point, Wiz, SentinelOne, CyberArk, NICE/Actimize, Verint, Claroty or Palo Alto Networks. The verified relationships retrieved were primarily venture/innovation relationships rather than disclosed enterprise procurement.7
In August 2020, Silverfort announced a $30 million Series B with participation from Citi Ventures; Silverfort also quoted Citi Israel’s venture head describing the company as having emerged from Citi’s Accelerator program.8 Silverfort’s January 2024 Series D release again listed Citi Ventures as an existing investor.9 These sources establish investment and accelerator ties, but do not state that Citibank, N.A. uses Silverfort in production.8, 9
In September 2020, BioCatch announced that Citi, Barclays, HSBC and NAB invested a combined $20 million and that each investing bank would receive two seats on a new BioCatch Client Innovation Board.10 BioCatch’s product domain is behavioral biometrics/fraud intelligence; Visa’s August 2026 acquisition announcement describes BioCatch as analyzing application, behavioral, device and network signals such as keystrokes, touch gestures and device handling.11 The retrieved sources do not state that Citibank, N.A. deployed BioCatch to authenticate its own customers.10, 11
On 25 November 2024, Capitolis announced a $20 million strategic investment led by Citi; Citi invested $5 million and obtained board representation.12 Globes described Capitolis in that transaction as an Israeli fintech company.13 On 6 October 2026, Citi led Capitolis’s $120 million Series E equity financing.14 These transactions establish strategic investment in Israeli-sector financial technology, but the retrieved releases do not establish a Citibank, N.A. software licence or production deployment.12, 14
Scale of dependency. No public evidence identified that any verified Israeli-origin technology relationship above is embedded in Citibank’s core network security, primary cloud platform or customer-data stack. The available evidence establishes investment, accelerator participation and innovation-board involvement, not technical dependency.8, 10, 12
Procurement and integrators. No public evidence identified of a systems integrator deploying an Israeli-origin product into Citibank under a named major technology programme within the retrieved sources.7
Surveillance, Biometrics & Retail Technology
Facial recognition and biometrics. The only verified Israeli-sector biometrics relationship retrieved was Citi’s 2020 investment in BioCatch and participation on its Client Innovation Board.10 BioCatch is a behavioral-biometrics/fraud-intelligence company rather than a facial-recognition vendor in the retrieved material.11 no public evidence identified that Citibank, N.A. deployed BioCatch, Trigo, BriefCam, AnyVision/Oosto, Trax or another Israeli-origin biometric system in production.10, 11
Predictive analytics and monitoring. No public evidence identified of Citibank, N.A. using Israeli-origin predictive-policing, sentiment-analysis, social-media-monitoring or workforce-surveillance technology.7
Third-party deployment. No public evidence identified that such surveillance or biometric technology reaches Citibank indirectly through a managed service or bundled platform.10, 11 The BioCatch relationship should therefore be treated as a verified strategic/innovation relationship with deployment status unresolved.10, 11
Cloud Infrastructure, Data Residency & Sovereign Cloud Participation
[pre-2020] Citi’s own 2014 account says its Technology Innovation Lab in Israel was created to develop tools for financial markets.15 [pre-2020] Citi’s 2018 global-lab release listed Israel among its innovation-lab locations.16 A January 2022 CTech profile described the Citi Israel Innovation Lab as a strategic technology hub for Citi worldwide, operating since 2011 and developing technologies in data, AI, blockchain and cybersecurity.17 This establishes an Israeli R&D/engineering footprint, but does not establish that customer data is stored in Israel or that an Israel-hosted production system serves Citi customers.15, 17
Current evidence confirms a Citi Ventures office at 121 Menachem Begin Street in Tel Aviv.5 Citi Ventures’ 2024 hires Rony Laufer and Ziv Idan are both listed in Tel Aviv and assigned to strategic and venture investments in Israel.18, 19
Data centre operations in Israel. No public evidence identified in the retrieved sources that Citibank or Citigroup operates, leases or colocates a production data centre in Israel.15, 5
Government cloud contracts / Project Nimbus. No public evidence identified of Citibank, Citigroup or Citi Ventures participating as a technology supplier in Project Nimbus or a comparable Israeli sovereign-cloud programme.15, 5, 7
Data sovereignty and resilience. No public evidence identified of Citi providing cloud/data-residency or infrastructure-resilience technology to Israeli state or military bodies. The state-facing relationships retrieved were fiscal-agency, underwriting, paying-agent and government-bond market roles, addressed in Section 4.6
Defence, Intelligence & Security Sector Technology Relationships
A January 2026 Israeli Ministry of Finance SEC exhibit states that the State of Israel’s fiscal-agency agreement is with Citibank, N.A., and that Citigroup Global Markets Inc. was one of the underwriters for a January 2026 sovereign-bond offering.6
These records establish group-level commercial relationships with the State of Israel in banking and capital markets; they do not describe a digital, cloud, AI, surveillance or military-technology service.6 no public evidence identified in the retrieved sources of a technology contract between Citibank/Citigroup and the Israeli Ministry of Defence, IDF or an Israeli intelligence service.6
Dual-use technology provision. No public evidence identified of a Citi-developed general-purpose technology platform being documented as deployed for Israeli military, intelligence or law-enforcement surveillance.15, 17, 6
Offensive cyber and weapons technology. No public evidence identified that Citibank, Citigroup or Citi Ventures develops, sells or maintains offensive-cyber tools, zero-day exploits or digital weapons for Israeli state actors.15, 7, 6
AI, Algorithmic & Autonomous Systems
Citi’s Israel R&D footprint has included AI-related work: the 2022 CTech profile says the Israel Innovation Lab developed technologies across data, AI, blockchain and cybersecurity for Citi’s international customers.17 Citi’s 2014 first-party description frames the lab as a financial-markets technology operation rather than a defence programme.15
AI/ML provision to Israeli state bodies. No public evidence identified that Citi provided AI/ML, computer vision or autonomous decision-support technology to an Israeli state, military or security body.15, 17, 6
Training data and model development. No public evidence identified that Citi AI models were trained on civilian-population, intercepted-communications or surveillance datasets originating from Israel or occupied territories.15, 17
Autonomous systems and lethality. No public evidence identified of Citi providing autonomous target-generation, threat-detection or tracking systems to Israeli military/security forces.15, 17, 6
Technology Ecosystem & R&D Footprint
[pre-2020] Citi says its Israel Technology Innovation Lab was established to combine Citi’s financial-markets position with Israel’s technology ecosystem.15 The 2022 CTech profile dates the lab to 2011, says Citi launched an Accelerator in 2013, and reports that the accelerator had helped more than 110 startups by that point.17 [pre-2020] A 2018 Citi release confirms Israel as part of Citi’s Global Innovation Labs network.16 A 2021 Citi event biography identified Ornit Shinar as Head of External Innovation and Venture Investing, Citi Israel, with responsibility for venture investing, external innovation and Citi’s Accelerator.20
Current venture activity is directly evidenced by Citi Ventures’ Tel Aviv office and 2024 appointments covering strategic and venture investments in Israel.5, 18, 19 Citi Ventures describes itself as investing in startups across FinTech, AI & Data, Security & Enterprise IT, DLT/Digital Assets and other financial-services technology areas.7
Verified Israeli-sector examples include Silverfort investment from 2020 through at least its 2024 financing,8, 9 Citi’s 2020 BioCatch investment and innovation-board participation,10 and Citi’s 2024 and 2026 strategic investments in Capitolis.12, 14, 13
Acquisitions. No public evidence identified in the bounded search of Citigroup/Citibank acquiring an Israeli-origin technology company.7
Patent and intellectual property relationships. No public evidence identified of a significant Citi patent-licensing or co-development agreement with Technion, Hebrew University, Weizmann Institute or another Israeli research institution.15, 7
Civil Society Scrutiny & Regulatory History
Target-specific searches were run against OHCHR-related material, A/HRC/59/23, Who Profits, AFSC, BankTrack and Don’t Buy Into Occupation. No target-specific technology source from those bodies was retrieved within the 36-search budget. Because the underlying reports were not separately opened, this is an evidence gap and does not establish that Citibank/Citigroup is absent from those materials.
NGO and academic reports. No public evidence identified in the retrieved source set of a published NGO or academic investigation specifically documenting Citibank/Citigroup technology provision to Israeli state/security bodies or settlements.
Boycott and divestment campaigns. No public evidence identified in the retrieved source set of an organised campaign specifically focused on Citi’s technology provision to Israel or occupied territories.
Regulatory and legal actions. No public evidence identified in the retrieved source set of an export-control, sanctions or regulatory action concerning Citi technology sales/services to Israeli state entities.
The strongest verified digital-domain evidence is therefore an Israeli technology R&D/innovation footprint and repeated strategic investment activity in Israeli-sector fintech, cybersecurity and behavioral-biometrics companies.15, 17, 8, 10, 12, 14 The retrieved evidence does not establish direct deployment of those companies’ products inside Citibank, Israeli sovereign-cloud participation, Israeli military/intelligence technology contracts, or settlement-specific digital deployment.
Footnotes
-
https://www.sec.gov/Archives/edgar/data/831001/000119312525308130/d36293d424b2.htm ↩ ↩2
-
https://kamakama.gov.il/en/economic-roles/supervision-and-regulation/list_supervised/ ↩
-
https://kamakama.gov.il/en/economic-roles/research-and-publications/all-research/research-papers/foreign-banks-activity-in-israel/ ↩
-
https://www.sec.gov/Archives/edgar/data/356173/000035617315000106/q77q1_forsubcustodiansciti.htm ↩
-
https://www.citigroup.com/ventures/contact-us.html ↩ ↩2 ↩3 ↩4 ↩5
-
https://www.sec.gov/Archives/edgar/data/52749/000110465926003199/tm263022d1_ex99-i.htm ↩ ↩2 ↩3 ↩4 ↩5 ↩6 ↩7 ↩8 ↩9
-
https://www.silverfort.com/press-news/news/silverfort-secures-30-million-in-series-b-funding/ ↩ ↩2 ↩3 ↩4 ↩5
-
https://www.silverfort.com/press-news/press/silverfort-raises-116m-to-deliver-a-unified-layer-of-identity-security-across-all-enterprise-resources/ ↩ ↩2 ↩3
-
https://www.biocatch.com/press-release/major-global-banks-invest-20-million-in-biocatch-and-join-american-express-ventures-on-new-client-innovation-board ↩ ↩2 ↩3 ↩4 ↩5 ↩6 ↩7 ↩8 ↩9
-
https://investor.visa.com/news/news-details/2026/Visa-to-Acquire-BioCatch/ ↩ ↩2 ↩3 ↩4 ↩5 ↩6
-
https://capitolis.com/capitolis-announces-new-strategic-investments-from-citi-morgan-stanley-state-street-and-ubs/ ↩ ↩2 ↩3 ↩4 ↩5
-
https://en.globes.co.il/en/article-global-banks-invest-20m-in-israeli-fintech-co-capitolis-1001495015 ↩ ↩2
-
https://capitolis.com/capitolis-announces-220-million-in-financing-including-120-million-series-e-at-1-9-billion-valuation-from-bank-of-america-barclays-bnp-paribas-citi-j-p-morgan-nomura-state-street-ubs-tra/ ↩ ↩2 ↩3 ↩4
-
https://www.citigroup.com/global/news/perspectives/2014/accelerating-technology-innovation ↩ ↩2 ↩3 ↩4 ↩5 ↩6 ↩7 ↩8 ↩9 ↩10 ↩11 ↩12 ↩13
-
https://www.citigroup.com/global/news/press-release/2018/citi-launches-innovation-lab-in-london ↩ ↩2
-
https://www.calcalistech.com/ctech/articles/0,7340,L-3926316,00.html ↩ ↩2 ↩3 ↩4 ↩5 ↩6 ↩7 ↩8 ↩9
-
https://www.citigroup.com/ventures/bio/rony-laufer.html ↩ ↩2
-
https://www.citi.com/icg/sa/digital_symposium/2021/speakers.html ↩